There is no field of medicine in which advances in therapy have been so closely linked to a better understanding of molecular medicine than in the area of hematologic malignancies. For example, recent insights into the understanding of Epstein-Barr virus have led to new treatment options for patients with posttransplant lymphoproliferative disorders, as discussed in the chapter by Dr. Richard Ambinder et al. Similarly, Drs. Slack and Gallagher discuss the explosion of recent information regarding the molecular pathogenesis of acute promyelocytic leukemia. This particular morphologic subtype of acute my eloid leukemia warrants separate discussion because of our increased under standing of the pathogenesis of leukemia, as well as the dramatic advances in outcome that have occurred with differentiation therapy provided by the vitamin A derivative aW-trans retinoic acid, as discussed in the chapter by Drs. Frankel and Powell. New approaches in the therapy of diffuse aggressive lymphomas in relationship to prognostic factors are discussed by Drs. Koc and Schenkein. Novel approaches to cutaneous T-cell lymphomas are discussed by Drs. Foss and Kuzel. Drs. Fonseca and Greipp discuss prognostic factors in myeloma, which are potentially important since they may serve to identify patients who may benefit from aggressive therapy such as bone marrow trans plantation, which is discussed in the chapter by Dr. David Vesole. State-of-the-art reviews are provided in the chapters on AIDS-related non- Hodgkin's lymphoma by Drs. Volm and Von Roenn, adult acute lympho blastic leukemia by Drs.
"synopsis" may belong to another edition of this title.
The field of medicine relating to haematologic malignancies is one in which advances in therapy have been closely linked to a better understanding of molecular medicine. This text aims to provide practitioners with an understanding of the constantly evolving concepts in this area.
"About this title" may belong to another edition of this title.
Seller: Basi6 International, Irving, TX, U.S.A.
Condition: Brand New. New. US edition. Expediting shipping for all USA and Europe orders excluding PO Box. Excellent Customer Service. Seller Inventory # ABEOCT25-118402
Seller: Romtrade Corp., STERLING HEIGHTS, MI, U.S.A.
Condition: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide. Seller Inventory # ABBB-159351
Seller: Books Puddle, Woodside, NY, U.S.A.
Condition: Used. pp. 396. Seller Inventory # 262169325
Seller: Majestic Books, Hounslow, United Kingdom
Condition: Used. pp. 396. Seller Inventory # 5678642
Quantity: 1 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: Used. pp. 396. Seller Inventory # 182169319
Seller: GreatBookPricesUK, Woodford Green, United Kingdom
Condition: New. Seller Inventory # 757544-n
Quantity: Over 20 available
Seller: moluna, Greven, Germany
Gebunden. Condition: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Preface. 1. New Classifications for Non-Hodgkin Lymphoma W.G. Finn, S.H. Kroft. 2. Epstein-Barr Virus and Lymphoma R.F. Ambinder, et al. 3. Therapy of Diffuse Aggressive Lymphomas Y. Koc, D.P. Schenkein. 4. The Molecular Biology of Acute Promyelocyti. Seller Inventory # 5970751
Quantity: Over 20 available
Seller: GreatBookPrices, Columbia, MD, U.S.A.
Condition: New. Seller Inventory # 757544-n
Seller: Ria Christie Collections, Uxbridge, United Kingdom
Condition: New. In English. Seller Inventory # ria9780792382065_new
Quantity: Over 20 available
Seller: preigu, Osnabrück, Germany
Buch. Condition: Neu. Diagnostic and Therapeutic Advances in Hematologic Malignancies | Leo I. Gordon (u. a.) | Buch | xiii | Englisch | 1998 | Springer US | EAN 9780792382065 | Verantwortliche Person für die EU: Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg, juergen[dot]hartmann[at]springer[dot]com | Anbieter: preigu Print on Demand. Seller Inventory # 102549267